“In Silico Characterization of a Novel Bioactive Compound Derived from Psidium Guajava 4-[5-(Pyridin-4-Yl)-1,2,4-Oxadiazol-3-Yl]-1,2,5-Oxadiazol-3-Amine: A Potential Inhibitor for Targeting Signaling Proteins Involved in Diabetes Development”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 16, no. 2, Mar. 2024, pp. 180-9, https://doi.org/10.25004/IJPSDR.2024.160207.